LD-2 disclosure · 2nd Quarter - Report
MEMSEL, INC.
Client
- Name
- MEMSEL, INC.
- Description
- Scientific research & development company
- Location
- Texas · United States of America
Registrant
- Description
- Government Relations Consultant
- Location
- Washington, District of Columbia, United States of America
Lobbying activities
3 issuesBudget/Appropriations
Advanced Wound Healing System and Phage Therapeutics, as follows: H.R.4365, Department of Defense Appropriations Act,FY2024 H.R.2670, National Defense Authorization Act for Fiscal Year 2024
LobbyistsJENNIFER CAVE · mr MICHAEL ANTHONY SHUPP · LAUREN ALEXIS BRESETTE
TargetedSENATE · HOUSE OF REPRESENTATIVES
Defense
Development of Advanced Wound Healing Systems H.R.4365, Department of Defense Appropriations Act,FY2024, Advanced Wound Healing System and Phage Therapeutics H.R.2670, National Defense Authorization Act for Fiscal Year 2024, Advanced Wound Healing System and Phage Therapeutics
LobbyistsJENNIFER CAVE · mr MICHAEL ANTHONY SHUPP · LAUREN ALEXIS BRESETTE
TargetedSENATE · HOUSE OF REPRESENTATIVES
Health Issues
Development of Advanced Wound Healing Systems H.R.4365, Department of Defense Appropriations Act,FY2024, Advanced Wound Healing System and Phage Therapeutics H.R.2670, National Defense Authorization Act for Fiscal Year 2024, Advanced Wound Healing System and Phage Therapeutics
LobbyistsJENNIFER CAVE · mr MICHAEL ANTHONY SHUPP · LAUREN ALEXIS BRESETTE